Diabetes, hyperglycaemia, and acute ischaemic stroke
暂无分享,去创建一个
L. Kappelle | G. Biessels | G. Rutten | M. Luitse | Geert Jan Biessels | Merel JA Luitse | Guy EHM Rutten | L Jaap Kappelle | Merel JA Luitse | M. J. Luitse
[1] Michael Stumvoll,et al. Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.
[2] L. Rydén,et al. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[3] D. Kansagara,et al. Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review , 2011, Annals of Internal Medicine.
[4] S. Bangalore,et al. Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials , 2011, Circulation.
[5] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[6] G. Biessels,et al. Hyperglycemia and cognitive outcome after ischemic stroke , 2008, Journal of the Neurological Sciences.
[7] M. Ezzati,et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.
[8] I. Deary,et al. Cognition and diabetes: a lifespan perspective , 2008, The Lancet Neurology.
[9] Ale Algra,et al. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke , 2011, The Lancet.
[10] Adnan I. Qureshi,et al. Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .
[11] M. Kaste,et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). , 2010, Archives of neurology.
[12] W. Vandertop,et al. Hyperglycemia in Aneurysmal Subarachnoid Hemorrhage: A Potentially Modifiable Risk Factor for Poor Outcome , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] J. S. Stevenson,et al. Older Adults , 1980, Suicide Prevention.
[14] C. Wolfe,et al. Association Between Diabetes and Stroke Subtype on Survival and Functional Outcome 3 Months After Stroke: Data From the European BIOMED Stroke Project , 2003, Stroke.
[15] John B Buse,et al. Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.
[16] Mark W Parsons,et al. Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study , 2002, Annals of neurology.
[17] J. Manson,et al. Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes , 2007, Diabetes Care.
[18] O. Pedersen,et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.
[19] H. Gerstein,et al. Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.
[20] K. Filion,et al. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. , 2011, The American journal of cardiology.
[21] D. Singer,et al. Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis , 2007 .
[22] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[23] A. Folsom,et al. Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study , 2006, Stroke.
[24] K. Khunti,et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial , 2011, The Lancet.
[25] P Glasziou,et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.
[26] B. Zinman,et al. Long-term effect of diabetes and its treatment on cognitive function , 2007 .
[27] C. Homko,et al. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. , 2006, Diabetes.
[28] M. S. Kirkman,et al. Response to Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61 , 2011, Diabetes Care.
[29] C. Mathers,et al. Preventing stroke: saving lives around the world , 2007, The Lancet Neurology.
[30] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[31] G. Eisenbarth. Update in type 1 diabetes. , 2007, The Journal of clinical endocrinology and metabolism.
[32] L. Nyström,et al. Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002 , 2008, Journal of internal medicine.
[33] J. Arenillas,et al. Acute Hyperglycemia State Is Associated With Lower tPA-Induced Recanalization Rates in Stroke Patients , 2005, Stroke.
[34] Miet Schetz,et al. Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units , 2006, Diabetes.
[35] Alan D. Lopez,et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.
[36] G. Biessels,et al. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management , 2010, Nature Reviews Neurology.
[37] H. Adams,et al. Acute blood glucose level and outcome from ischemic stroke , 1999, Neurology.
[38] Anushka Patel Fracp. Eff ects of a fi xed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007 .
[39] S. Grundy,et al. The metabolic syndrome , 2003, The Lancet.
[40] Kamlesh Khunti,et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial , 2011, The Lancet.
[41] Diederick Grobbee,et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.
[42] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[43] E. Guallar,et al. Meta-Analysis of Randomized Educational and Behavioral Interventions in Type 2 Diabetes , 2003, The Diabetes educator.
[44] M. Sande. Glucose Regulation in Acute Stroke Patients (GRASP) Trial: A Randomized Pilot Trial , 2010 .
[45] P. Chan,et al. Influence of Hyperglycemia on Oxidative Stress and Matrix Metalloproteinase-9 Activation After Focal Cerebral Ischemia/Reperfusion in Rats: Relation to Blood-Brain Barrier Dysfunction , 2007, Stroke.
[46] L. Kappelle,et al. Subjecting Acute Ischemic Stroke Patients to Continuous Tube Feeding and an Intensive Computerized Protocol Establishes Tight Glycemic Control , 2010, Neurocritical care.
[47] Gary A. Ford,et al. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. , 2008, Cerebrovascular diseases.
[48] Steven Snapinn,et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.
[49] J. Preiser,et al. Stress hyperglycaemia , 2009, The Lancet.
[50] Deepak L. Bhatt,et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. , 2002, The American journal of cardiology.
[51] C. Wolfe,et al. Cause of Stroke Recurrence Is Multifactorial: Patterns, Risk Factors, and Outcomes of Stroke Recurrence in the South London Stroke Register , 2003, Stroke.
[52] J. Nunnelee. Review of an article: The ADVANCE Collaborative Group. (2008). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. NEJM 2008;358:2560-2572. , 2008 .
[53] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[54] Thrombolysis Outcomes in Acute Ischemic Stroke Patients With Prior Stroke and Diabetes Mellitus , 2012, Neurology.
[55] Rury R Holman,et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. , 2008, The New England journal of medicine.
[56] P. Rothwell,et al. Long-Term Durability of Carotid Endarterectomy for Symptomatic Stenosis and Risk Factors for Late Postoperative Stroke , 2002, Stroke.
[57] A. Morris,et al. ABC of arterial and venous disease: vascular complications of diabetes. , 2000, BMJ.
[58] Askiel Bruno,et al. Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial , 2008, Stroke.
[59] A. Thanopoulou,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[60] R. Busse,et al. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[61] M. Kaste,et al. Diabetes mellitus and ischemic stroke in the young , 2011, Neurology.
[62] Rena R Wing,et al. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. , 2010, Archives of internal medicine.
[63] M. Hennerici,et al. Pragmatic Management of Hyperglycaemia in Acute Ischaemic Stroke: Safety and Feasibility of Intensive Intravenous Insulin Treatment , 2008, Cerebrovascular Diseases.
[64] E. Gale,et al. Diabetes and gender , 2001, Diabetologia.
[65] M. Walters,et al. A Randomised, Controlled Pilot Study to Investigate the Potential Benefit of Intervention with Insulin in Hyperglycaemic Acute Ischaemic Stroke Patients , 2006, Cerebrovascular Diseases.
[66] A. T. N. Group,et al. Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes. , 2001, Diabetologia.
[67] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.
[68] Anushka Patel,et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007, The Lancet.
[69] Jeroen J. Bax,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[70] S. Pendlebury,et al. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis , 2009, The Lancet Neurology.
[71] J. Gaughan,et al. Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: Impact of hyperglycemia , 2007, Thrombosis and Haemostasis.
[72] L. Kappelle,et al. Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[73] M. Kamalesh,et al. Long Term Postischemic Stroke Mortality in Diabetes: A Veteran Cohort Analysis , 2008, Stroke.
[74] C. Sudlow,et al. Are Lacunar Strokes Really Different?: A Systematic Review of Differences in Risk Factor Profiles Between Lacunar and Nonlacunar Infarcts , 2005, Stroke.
[75] R. Rosenfeld. Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[76] Anders Green,et al. The changing world demography of type 2 diabetes , 2003, Diabetes/metabolism research and reviews.
[77] P. Sandercock,et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) , 2007, The Lancet Neurology.
[78] Seemant Chaturvedi,et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.
[79] F. Gueyffier,et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials , 2011, BMJ : British Medical Journal.
[80] J H Devries,et al. Hyperglycemia: a prothrombotic factor? , 2010, Journal of thrombosis and haemostasis : JTH.
[81] Allan Vaag,et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus , 2011, The Cochrane database of systematic reviews.
[82] H. Yamashita,et al. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study) , 2010, Diabetologia.
[83] A. Camm,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.
[84] A. Cheung,et al. Blood pressure control in type 2 diabetes mellitus. , 2010, American Journal of Kidney Diseases.
[85] R. Marfella,et al. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.
[86] P. Lavin. Hyperglycemic hemianopia: A reversible complication of non-ketotic hyperglycemia , 2005, Neurology.
[87] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[88] Mathijs Vogelzang,et al. Computer-assisted glucose control in critically ill patients , 2008, Intensive Care Medicine.
[89] P. English,et al. Hyperglycaemic crises and lactic acidosis in diabetes mellitus , 2004, Postgraduate Medical Journal.
[90] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[91] Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .
[92] Karen L. Furie,et al. Response to Letter by Naylor Regarding Article, “Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association” , 2011 .
[93] N. Kawai,et al. Hyperglycemia induces progressive changes in the cerebral microvasculature and blood-brain barrier transport during focal cerebral ischemia. , 1998, Acta neurochirurgica. Supplement.
[94] Michael E. Miller,et al. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .
[95] J. Pankow,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[96] G. Moneta. Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial , 2009 .
[97] M. Bellolio,et al. Insulin for glycaemic control in acute ischaemic stroke. , 2014, The Cochrane database of systematic reviews.
[98] N. Bornstein,et al. Persistent Hyperglycemia at 24–48 h in Acute Hyperglycemic Stroke Patients Is Not Associated with a Worse Functional Outcome , 2011, Cerebrovascular Diseases.
[99] C. Bémeur,et al. Increased oxidative stress during hyperglycemic cerebral ischemia , 2007, Neurochemistry International.
[100] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[101] K. Forrest,et al. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. , 1998, International journal of epidemiology.
[102] E. Debing,et al. Diabetes Mellitus is a Predictor for Early Adverse Outcome After Carotid Endarterectomy , 2011, Vascular and endovascular surgery.
[103] M. Kaste,et al. Post-Thrombolytic Hyperglycemia and 3-Month Outcome in Acute Ischemic Stroke , 2010, Cerebrovascular Diseases.
[104] Liu Xinbing,et al. Intensive insulin therapy for the critically ill patients with stress hyperglycemia , 2008 .
[105] G. Pellegrini,et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat , 2001, Acta Diabetologica.
[106] Cheng Gangge. Carotid endarterectomy for symptomatic carotid stenosis , 2011 .
[107] Tien Yin Wong,et al. Diabetic retinopathy , 2010, The Lancet.
[108] R. Koopman,et al. Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way , 2006, Diabetologia.
[109] Denis Daneman,et al. Type 1 diabetes , 2018, The Lancet.
[110] A. Shah,et al. Neuronal Nitric Oxide Synthase and Human Vascular Regulation , 2009, Trends in cardiovascular medicine.
[111] J. Szaflarski,et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. , 2005, Diabetes care.
[112] J. Danesh,et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.
[113] J. De Keyser,et al. Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. , 2007, Brain : a journal of neurology.
[114] T. Wadden,et al. Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes , 2011, Diabetes Care.
[115] R. Sacco,et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. , 2010, Archives of neurology.
[116] Y. Kokubo,et al. Diabetes Mellitus and Risk of Stroke and Its Subtypes Among Japanese: The Japan Public Health Center Study , 2011, Stroke.
[117] Shobha S Rao,et al. Impaired glucose tolerance and impaired fasting glucose. , 2004, American family physician.
[118] L. Bouter,et al. Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study , 2005, Circulation.
[119] Y. Jang,et al. Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .
[120] K. Rexrode,et al. Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes: the Nurses’ Health Study , 2007, Diabetes Care.
[121] T. Kent,et al. Perfusion Deficit Parallels Exacerbation of Cerebral Ischemia/Reperfusion Injury in Hyperglycemic Rats , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[122] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[123] P. Cleary,et al. Long-term effect of diabetes and its treatment on cognitive function. , 2007, The New England journal of medicine.
[124] V. Basevi. Standards of Medical Care in Diabetes—2011 , 2011, Diabetes Care.
[125] Cynthia Balion,et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. , 2007, Diabetes research and clinical practice.
[126] I. D. de Boer,et al. Fasting and Post-Glucose Load Measures of Insulin Resistance and Risk of Ischemic Stroke in Older Adults , 2011, Stroke.
[127] R. DeFronzo,et al. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. , 2011, The American journal of cardiology.
[128] G. Grunkemeier,et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[129] A. Stępień,et al. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. , 2011, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[130] J. Shaw,et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[131] B. C. Choi,et al. Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey , 2001, Diabetologia.
[132] J. Schulte‐Mönting,et al. Hyperglycemia in Patients with Focal Cerebral Ischemia after Intravenous Thrombolysis: Influence on Clinical Outcome and Infarct Size , 2002, Cerebrovascular Diseases.
[133] K. Muir,et al. Hyperglycaemia and Infarct Size in Animal Models of Middle Cerebral Artery Occlusion: Systematic Review and Meta-Analysis , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[134] V. Melnyk,et al. Hyperglycemia after Acute Ischemic Stroke: Prediction, Significance and Immediate Control with Insulin-Potassium-Saline-Magnesium Infusions , 2005, Heart Drug.
[135] 入江 潤一郎,et al. Glucose control and vascular complications in veterans with type 2 diabetes , 2009 .